Le Lézard
Classified in: Covid-19 virus
Subjects: Conference, Product/Service, Webcast

AM Best to Discuss Reinsurance Industry Outlook, COVID-19 Impact, European Insurance Market Segment at Annual Briefing


AM Best will present a market briefing exploring the state of the global reinsurance industry on 22 September 2020, 3:00 p.m.?4:30 p.m. (CEST).

During the event, AM Best senior rating analysts will discuss the rationale behind the rating agency's stable market segment outlook on the reinsurance industry and offer opinions on the key rating issues affecting reinsurers. The analysts also will explore the major strains that primary companies are facing that could have an impact on the reinsurance market. Other discussion topics during the presentation, which typically has been held in Zurich, a longstanding reinsurance industry hub, include an overview of the market segment outlooks for select European countries, and how the COVID-19 pandemic is shaping the industry.

Panelists during AM Best's Reinsurance Market Briefing ? Global will include:

Register now: http://www.ambest.com/webinars/zurich20/index.html.

Attendees can submit advance questions during registration or by emailing [email protected]. Playback will be available to registered viewers shortly after the event.

AM Best recently released its annual market segment report on the reinsurance industry. The report, "Global Reinsurers Maintain Equilibrium Through COVID-19 Turbulence," includes AM Best's highly regarded annual ranking of the Top 50 Global Reinsurance Groups. The report can be viewed at http://www3.ambest.com/bestweek/purchase.asp?record_code=300732.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2020 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED.


These press releases may also interest you

at 14:45
The "Yeast - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Yeast Market to Reach $11.6 Billion by 2030 The global market for Yeast estimated at US$6.2 Billion in the year 2023, is projected to reach...

at 14:15
Natuzzi chooses the stage of two among the most relevant global furniture events, High Point Market in North Carolina, and the Design Week in Milan, to unveil the dense program of events and projects that will mark the calendar of its 65th...

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...



News published on and distributed by: